ArticleBiomicrofluidics2022

RapidQ: A reader-free microfluidic platform for the quantitation of antibodies against the SARS-CoV-2 spike protein.

Juha-Pekka Mattila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.